Pharma & Healthcare
Global Functional Dyspepsia Drug Market Research Report 2024
- Feb 19, 24
- ID: 51999
- Pages: 95
- Figures: 203
- Views: 13
Functional dyspepsia, also known as non-ulcer dyspepsia or indigestion, is a term used to describe a group of symptoms affecting the gastrointestinal tract, including stomach pain or discomfort, nausea, bloating and belching. The condition is diagnosed when no obvious cause can be found for the symptoms present, though a small percentage of cases are caused by infection with the germ Helicobacter pylori.
The global Functional Dyspepsia Drug market was valued at US$ 5948.9 million in 2023 and is anticipated to reach US$ 7234.2 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.
North America is the largest consumer of Functional Dyspepsia Drug in global market, with a consumption market share of 38.71% in 2019. Market is not concentrated.
This report aims to provide a comprehensive presentation of the global market for Functional Dyspepsia Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Functional Dyspepsia Drug.
Report Scope
The Functional Dyspepsia Drug market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Functional Dyspepsia Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Functional Dyspepsia Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Sumitomo
Cadila Pharmaceuticals
Teva
Johnson & Johnson
Pfizer
Sanofi
AstraZeneca
Jiangsu Aosaikang Pharma
Eisai
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Segment by Type
Prokinetic Drugs
Gastric Antisecretory Drugs
Others
Segment by Application
Hospitals
Drugstores
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Functional Dyspepsia Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Functional Dyspepsia Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Functional Dyspepsia Drug market was valued at US$ 5948.9 million in 2023 and is anticipated to reach US$ 7234.2 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.
North America is the largest consumer of Functional Dyspepsia Drug in global market, with a consumption market share of 38.71% in 2019. Market is not concentrated.
This report aims to provide a comprehensive presentation of the global market for Functional Dyspepsia Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Functional Dyspepsia Drug.
Report Scope
The Functional Dyspepsia Drug market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Functional Dyspepsia Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Functional Dyspepsia Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Sumitomo
Cadila Pharmaceuticals
Teva
Johnson & Johnson
Pfizer
Sanofi
AstraZeneca
Jiangsu Aosaikang Pharma
Eisai
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Segment by Type
Prokinetic Drugs
Gastric Antisecretory Drugs
Others
Segment by Application
Hospitals
Drugstores
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Functional Dyspepsia Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Functional Dyspepsia Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Functional Dyspepsia Drug Market Overview
1.1 Product Overview and Scope of Functional Dyspepsia Drug
1.2 Functional Dyspepsia Drug Segment by Type
1.2.1 Global Functional Dyspepsia Drug Market Value Comparison by Type (2024-2030)
1.2.2 Prokinetic Drugs
1.2.3 Gastric Antisecretory Drugs
1.2.4 Others
1.3 Functional Dyspepsia Drug Segment by Application
1.3.1 Global Functional Dyspepsia Drug Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Drugstores
1.4 Global Functional Dyspepsia Drug Market Size Estimates and Forecasts
1.4.1 Global Functional Dyspepsia Drug Revenue 2019-2030
1.4.2 Global Functional Dyspepsia Drug Sales 2019-2030
1.4.3 Global Functional Dyspepsia Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Functional Dyspepsia Drug Market Competition by Manufacturers
2.1 Global Functional Dyspepsia Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Functional Dyspepsia Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Functional Dyspepsia Drug Average Price by Manufacturers (2019-2024)
2.4 Global Functional Dyspepsia Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Functional Dyspepsia Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Functional Dyspepsia Drug, Product Type & Application
2.7 Functional Dyspepsia Drug Market Competitive Situation and Trends
2.7.1 Functional Dyspepsia Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Functional Dyspepsia Drug Players Market Share by Revenue
2.7.3 Global Functional Dyspepsia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Functional Dyspepsia Drug Retrospective Market Scenario by Region
3.1 Global Functional Dyspepsia Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Functional Dyspepsia Drug Global Functional Dyspepsia Drug Sales by Region: 2019-2030
3.2.1 Global Functional Dyspepsia Drug Sales by Region: 2019-2024
3.2.2 Global Functional Dyspepsia Drug Sales by Region: 2025-2030
3.3 Global Functional Dyspepsia Drug Global Functional Dyspepsia Drug Revenue by Region: 2019-2030
3.3.1 Global Functional Dyspepsia Drug Revenue by Region: 2019-2024
3.3.2 Global Functional Dyspepsia Drug Revenue by Region: 2025-2030
3.4 North America Functional Dyspepsia Drug Market Facts & Figures by Country
3.4.1 North America Functional Dyspepsia Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Functional Dyspepsia Drug Sales by Country (2019-2030)
3.4.3 North America Functional Dyspepsia Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Functional Dyspepsia Drug Market Facts & Figures by Country
3.5.1 Europe Functional Dyspepsia Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Functional Dyspepsia Drug Sales by Country (2019-2030)
3.5.3 Europe Functional Dyspepsia Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Functional Dyspepsia Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Functional Dyspepsia Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Functional Dyspepsia Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Functional Dyspepsia Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Functional Dyspepsia Drug Market Facts & Figures by Country
3.7.1 Latin America Functional Dyspepsia Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Functional Dyspepsia Drug Sales by Country (2019-2030)
3.7.3 Latin America Functional Dyspepsia Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Functional Dyspepsia Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Functional Dyspepsia Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Functional Dyspepsia Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Functional Dyspepsia Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Functional Dyspepsia Drug Sales by Type (2019-2030)
4.1.1 Global Functional Dyspepsia Drug Sales by Type (2019-2024)
4.1.2 Global Functional Dyspepsia Drug Sales by Type (2025-2030)
4.1.3 Global Functional Dyspepsia Drug Sales Market Share by Type (2019-2030)
4.2 Global Functional Dyspepsia Drug Revenue by Type (2019-2030)
4.2.1 Global Functional Dyspepsia Drug Revenue by Type (2019-2024)
4.2.2 Global Functional Dyspepsia Drug Revenue by Type (2025-2030)
4.2.3 Global Functional Dyspepsia Drug Revenue Market Share by Type (2019-2030)
4.3 Global Functional Dyspepsia Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Functional Dyspepsia Drug Sales by Application (2019-2030)
5.1.1 Global Functional Dyspepsia Drug Sales by Application (2019-2024)
5.1.2 Global Functional Dyspepsia Drug Sales by Application (2025-2030)
5.1.3 Global Functional Dyspepsia Drug Sales Market Share by Application (2019-2030)
5.2 Global Functional Dyspepsia Drug Revenue by Application (2019-2030)
5.2.1 Global Functional Dyspepsia Drug Revenue by Application (2019-2024)
5.2.2 Global Functional Dyspepsia Drug Revenue by Application (2025-2030)
5.2.3 Global Functional Dyspepsia Drug Revenue Market Share by Application (2019-2030)
5.3 Global Functional Dyspepsia Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Functional Dyspepsia Drug Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Sumitomo
6.2.1 Sumitomo Corporation Information
6.2.2 Sumitomo Description and Business Overview
6.2.3 Sumitomo Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sumitomo Functional Dyspepsia Drug Product Portfolio
6.2.5 Sumitomo Recent Developments/Updates
6.3 Cadila Pharmaceuticals
6.3.1 Cadila Pharmaceuticals Corporation Information
6.3.2 Cadila Pharmaceuticals Description and Business Overview
6.3.3 Cadila Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cadila Pharmaceuticals Functional Dyspepsia Drug Product Portfolio
6.3.5 Cadila Pharmaceuticals Recent Developments/Updates
6.4 Teva
6.4.1 Teva Corporation Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Functional Dyspepsia Drug Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporation Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Johnson & Johnson Functional Dyspepsia Drug Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer Functional Dyspepsia Drug Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Functional Dyspepsia Drug Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Corporation Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 AstraZeneca Functional Dyspepsia Drug Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 Jiangsu Aosaikang Pharma
6.9.1 Jiangsu Aosaikang Pharma Corporation Information
6.9.2 Jiangsu Aosaikang Pharma Description and Business Overview
6.9.3 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Product Portfolio
6.9.5 Jiangsu Aosaikang Pharma Recent Developments/Updates
6.10 Eisai
6.10.1 Eisai Corporation Information
6.10.2 Eisai Description and Business Overview
6.10.3 Eisai Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Eisai Functional Dyspepsia Drug Product Portfolio
6.10.5 Eisai Recent Developments/Updates
6.11 Kyowa Kirin Pharmaceuticals
6.11.1 Kyowa Kirin Pharmaceuticals Corporation Information
6.11.2 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Description and Business Overview
6.11.3 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Product Portfolio
6.11.5 Kyowa Kirin Pharmaceuticals Recent Developments/Updates
6.12 Hanmi Pharm
6.12.1 Hanmi Pharm Corporation Information
6.12.2 Hanmi Pharm Functional Dyspepsia Drug Description and Business Overview
6.12.3 Hanmi Pharm Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Hanmi Pharm Functional Dyspepsia Drug Product Portfolio
6.12.5 Hanmi Pharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Functional Dyspepsia Drug Industry Chain Analysis
7.2 Functional Dyspepsia Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Functional Dyspepsia Drug Production Mode & Process
7.4 Functional Dyspepsia Drug Sales and Marketing
7.4.1 Functional Dyspepsia Drug Sales Channels
7.4.2 Functional Dyspepsia Drug Distributors
7.5 Functional Dyspepsia Drug Customers
8 Functional Dyspepsia Drug Market Dynamics
8.1 Functional Dyspepsia Drug Industry Trends
8.2 Functional Dyspepsia Drug Market Drivers
8.3 Functional Dyspepsia Drug Market Challenges
8.4 Functional Dyspepsia Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Functional Dyspepsia Drug
1.2 Functional Dyspepsia Drug Segment by Type
1.2.1 Global Functional Dyspepsia Drug Market Value Comparison by Type (2024-2030)
1.2.2 Prokinetic Drugs
1.2.3 Gastric Antisecretory Drugs
1.2.4 Others
1.3 Functional Dyspepsia Drug Segment by Application
1.3.1 Global Functional Dyspepsia Drug Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Drugstores
1.4 Global Functional Dyspepsia Drug Market Size Estimates and Forecasts
1.4.1 Global Functional Dyspepsia Drug Revenue 2019-2030
1.4.2 Global Functional Dyspepsia Drug Sales 2019-2030
1.4.3 Global Functional Dyspepsia Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Functional Dyspepsia Drug Market Competition by Manufacturers
2.1 Global Functional Dyspepsia Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Functional Dyspepsia Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Functional Dyspepsia Drug Average Price by Manufacturers (2019-2024)
2.4 Global Functional Dyspepsia Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Functional Dyspepsia Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Functional Dyspepsia Drug, Product Type & Application
2.7 Functional Dyspepsia Drug Market Competitive Situation and Trends
2.7.1 Functional Dyspepsia Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Functional Dyspepsia Drug Players Market Share by Revenue
2.7.3 Global Functional Dyspepsia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Functional Dyspepsia Drug Retrospective Market Scenario by Region
3.1 Global Functional Dyspepsia Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Functional Dyspepsia Drug Global Functional Dyspepsia Drug Sales by Region: 2019-2030
3.2.1 Global Functional Dyspepsia Drug Sales by Region: 2019-2024
3.2.2 Global Functional Dyspepsia Drug Sales by Region: 2025-2030
3.3 Global Functional Dyspepsia Drug Global Functional Dyspepsia Drug Revenue by Region: 2019-2030
3.3.1 Global Functional Dyspepsia Drug Revenue by Region: 2019-2024
3.3.2 Global Functional Dyspepsia Drug Revenue by Region: 2025-2030
3.4 North America Functional Dyspepsia Drug Market Facts & Figures by Country
3.4.1 North America Functional Dyspepsia Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Functional Dyspepsia Drug Sales by Country (2019-2030)
3.4.3 North America Functional Dyspepsia Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Functional Dyspepsia Drug Market Facts & Figures by Country
3.5.1 Europe Functional Dyspepsia Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Functional Dyspepsia Drug Sales by Country (2019-2030)
3.5.3 Europe Functional Dyspepsia Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Functional Dyspepsia Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Functional Dyspepsia Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Functional Dyspepsia Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Functional Dyspepsia Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Functional Dyspepsia Drug Market Facts & Figures by Country
3.7.1 Latin America Functional Dyspepsia Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Functional Dyspepsia Drug Sales by Country (2019-2030)
3.7.3 Latin America Functional Dyspepsia Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Functional Dyspepsia Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Functional Dyspepsia Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Functional Dyspepsia Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Functional Dyspepsia Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Functional Dyspepsia Drug Sales by Type (2019-2030)
4.1.1 Global Functional Dyspepsia Drug Sales by Type (2019-2024)
4.1.2 Global Functional Dyspepsia Drug Sales by Type (2025-2030)
4.1.3 Global Functional Dyspepsia Drug Sales Market Share by Type (2019-2030)
4.2 Global Functional Dyspepsia Drug Revenue by Type (2019-2030)
4.2.1 Global Functional Dyspepsia Drug Revenue by Type (2019-2024)
4.2.2 Global Functional Dyspepsia Drug Revenue by Type (2025-2030)
4.2.3 Global Functional Dyspepsia Drug Revenue Market Share by Type (2019-2030)
4.3 Global Functional Dyspepsia Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Functional Dyspepsia Drug Sales by Application (2019-2030)
5.1.1 Global Functional Dyspepsia Drug Sales by Application (2019-2024)
5.1.2 Global Functional Dyspepsia Drug Sales by Application (2025-2030)
5.1.3 Global Functional Dyspepsia Drug Sales Market Share by Application (2019-2030)
5.2 Global Functional Dyspepsia Drug Revenue by Application (2019-2030)
5.2.1 Global Functional Dyspepsia Drug Revenue by Application (2019-2024)
5.2.2 Global Functional Dyspepsia Drug Revenue by Application (2025-2030)
5.2.3 Global Functional Dyspepsia Drug Revenue Market Share by Application (2019-2030)
5.3 Global Functional Dyspepsia Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Functional Dyspepsia Drug Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Sumitomo
6.2.1 Sumitomo Corporation Information
6.2.2 Sumitomo Description and Business Overview
6.2.3 Sumitomo Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sumitomo Functional Dyspepsia Drug Product Portfolio
6.2.5 Sumitomo Recent Developments/Updates
6.3 Cadila Pharmaceuticals
6.3.1 Cadila Pharmaceuticals Corporation Information
6.3.2 Cadila Pharmaceuticals Description and Business Overview
6.3.3 Cadila Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cadila Pharmaceuticals Functional Dyspepsia Drug Product Portfolio
6.3.5 Cadila Pharmaceuticals Recent Developments/Updates
6.4 Teva
6.4.1 Teva Corporation Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Functional Dyspepsia Drug Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporation Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Johnson & Johnson Functional Dyspepsia Drug Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer Functional Dyspepsia Drug Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Functional Dyspepsia Drug Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Corporation Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 AstraZeneca Functional Dyspepsia Drug Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 Jiangsu Aosaikang Pharma
6.9.1 Jiangsu Aosaikang Pharma Corporation Information
6.9.2 Jiangsu Aosaikang Pharma Description and Business Overview
6.9.3 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Product Portfolio
6.9.5 Jiangsu Aosaikang Pharma Recent Developments/Updates
6.10 Eisai
6.10.1 Eisai Corporation Information
6.10.2 Eisai Description and Business Overview
6.10.3 Eisai Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Eisai Functional Dyspepsia Drug Product Portfolio
6.10.5 Eisai Recent Developments/Updates
6.11 Kyowa Kirin Pharmaceuticals
6.11.1 Kyowa Kirin Pharmaceuticals Corporation Information
6.11.2 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Description and Business Overview
6.11.3 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Product Portfolio
6.11.5 Kyowa Kirin Pharmaceuticals Recent Developments/Updates
6.12 Hanmi Pharm
6.12.1 Hanmi Pharm Corporation Information
6.12.2 Hanmi Pharm Functional Dyspepsia Drug Description and Business Overview
6.12.3 Hanmi Pharm Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Hanmi Pharm Functional Dyspepsia Drug Product Portfolio
6.12.5 Hanmi Pharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Functional Dyspepsia Drug Industry Chain Analysis
7.2 Functional Dyspepsia Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Functional Dyspepsia Drug Production Mode & Process
7.4 Functional Dyspepsia Drug Sales and Marketing
7.4.1 Functional Dyspepsia Drug Sales Channels
7.4.2 Functional Dyspepsia Drug Distributors
7.5 Functional Dyspepsia Drug Customers
8 Functional Dyspepsia Drug Market Dynamics
8.1 Functional Dyspepsia Drug Industry Trends
8.2 Functional Dyspepsia Drug Market Drivers
8.3 Functional Dyspepsia Drug Market Challenges
8.4 Functional Dyspepsia Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Functional Dyspepsia Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Functional Dyspepsia Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Functional Dyspepsia Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Functional Dyspepsia Drug Sales (M Units) of Key Manufacturers (2019-2024)
Table 5. Global Functional Dyspepsia Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Functional Dyspepsia Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Functional Dyspepsia Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Functional Dyspepsia Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Functional Dyspepsia Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Functional Dyspepsia Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Functional Dyspepsia Drug, Product Type & Application
Table 12. Global Key Manufacturers of Functional Dyspepsia Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Functional Dyspepsia Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Functional Dyspepsia Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Functional Dyspepsia Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Functional Dyspepsia Drug Sales by Region (2019-2024) & (M Units)
Table 18. Global Functional Dyspepsia Drug Sales Market Share by Region (2019-2024)
Table 19. Global Functional Dyspepsia Drug Sales by Region (2025-2030) & (M Units)
Table 20. Global Functional Dyspepsia Drug Sales Market Share by Region (2025-2030)
Table 21. Global Functional Dyspepsia Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Functional Dyspepsia Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Functional Dyspepsia Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Functional Dyspepsia Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Functional Dyspepsia Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Functional Dyspepsia Drug Sales by Country (2019-2024) & (M Units)
Table 27. North America Functional Dyspepsia Drug Sales by Country (2025-2030) & (M Units)
Table 28. North America Functional Dyspepsia Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Functional Dyspepsia Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Functional Dyspepsia Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Functional Dyspepsia Drug Sales by Country (2019-2024) & (M Units)
Table 32. Europe Functional Dyspepsia Drug Sales by Country (2025-2030) & (M Units)
Table 33. Europe Functional Dyspepsia Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Functional Dyspepsia Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Functional Dyspepsia Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Functional Dyspepsia Drug Sales by Region (2019-2024) & (M Units)
Table 37. Asia Pacific Functional Dyspepsia Drug Sales by Region (2025-2030) & (M Units)
Table 38. Asia Pacific Functional Dyspepsia Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Functional Dyspepsia Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Functional Dyspepsia Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Functional Dyspepsia Drug Sales by Country (2019-2024) & (M Units)
Table 42. Latin America Functional Dyspepsia Drug Sales by Country (2025-2030) & (M Units)
Table 43. Latin America Functional Dyspepsia Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Functional Dyspepsia Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Functional Dyspepsia Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Functional Dyspepsia Drug Sales by Country (2019-2024) & (M Units)
Table 47. Middle East & Africa Functional Dyspepsia Drug Sales by Country (2025-2030) & (M Units)
Table 48. Middle East & Africa Functional Dyspepsia Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Functional Dyspepsia Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Functional Dyspepsia Drug Sales (M Units) by Type (2019-2024)
Table 51. Global Functional Dyspepsia Drug Sales (M Units) by Type (2025-2030)
Table 52. Global Functional Dyspepsia Drug Sales Market Share by Type (2019-2024)
Table 53. Global Functional Dyspepsia Drug Sales Market Share by Type (2025-2030)
Table 54. Global Functional Dyspepsia Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Functional Dyspepsia Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Functional Dyspepsia Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Functional Dyspepsia Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Functional Dyspepsia Drug Price (US$/Unit) by Type (2019-2024)
Table 59. Global Functional Dyspepsia Drug Price (US$/Unit) by Type (2025-2030)
Table 60. Global Functional Dyspepsia Drug Sales (M Units) by Application (2019-2024)
Table 61. Global Functional Dyspepsia Drug Sales (M Units) by Application (2025-2030)
Table 62. Global Functional Dyspepsia Drug Sales Market Share by Application (2019-2024)
Table 63. Global Functional Dyspepsia Drug Sales Market Share by Application (2025-2030)
Table 64. Global Functional Dyspepsia Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Functional Dyspepsia Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Functional Dyspepsia Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Functional Dyspepsia Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Functional Dyspepsia Drug Price (US$/Unit) by Application (2019-2024)
Table 69. Global Functional Dyspepsia Drug Price (US$/Unit) by Application (2025-2030)
Table 70. Bayer Corporation Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Bayer Functional Dyspepsia Drug Product
Table 74. Bayer Recent Developments/Updates
Table 75. Sumitomo Corporation Information
Table 76. Sumitomo Description and Business Overview
Table 77. Sumitomo Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Sumitomo Functional Dyspepsia Drug Product
Table 79. Sumitomo Recent Developments/Updates
Table 80. Cadila Pharmaceuticals Corporation Information
Table 81. Cadila Pharmaceuticals Description and Business Overview
Table 82. Cadila Pharmaceuticals Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Cadila Pharmaceuticals Functional Dyspepsia Drug Product
Table 84. Cadila Pharmaceuticals Recent Developments/Updates
Table 85. Teva Corporation Information
Table 86. Teva Description and Business Overview
Table 87. Teva Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Teva Functional Dyspepsia Drug Product
Table 89. Teva Recent Developments/Updates
Table 90. Johnson & Johnson Corporation Information
Table 91. Johnson & Johnson Description and Business Overview
Table 92. Johnson & Johnson Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Johnson & Johnson Functional Dyspepsia Drug Product
Table 94. Johnson & Johnson Recent Developments/Updates
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Pfizer Functional Dyspepsia Drug Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Sanofi Corporation Information
Table 101. Sanofi Description and Business Overview
Table 102. Sanofi Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Sanofi Functional Dyspepsia Drug Product
Table 104. Sanofi Recent Developments/Updates
Table 105. AstraZeneca Corporation Information
Table 106. AstraZeneca Description and Business Overview
Table 107. AstraZeneca Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. AstraZeneca Functional Dyspepsia Drug Product
Table 109. AstraZeneca Recent Developments/Updates
Table 110. Jiangsu Aosaikang Pharma Corporation Information
Table 111. Jiangsu Aosaikang Pharma Description and Business Overview
Table 112. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Product
Table 114. Jiangsu Aosaikang Pharma Recent Developments/Updates
Table 115. Eisai Corporation Information
Table 116. Eisai Description and Business Overview
Table 117. Eisai Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Eisai Functional Dyspepsia Drug Product
Table 119. Eisai Recent Developments/Updates
Table 120. Kyowa Kirin Pharmaceuticals Corporation Information
Table 121. Kyowa Kirin Pharmaceuticals Description and Business Overview
Table 122. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Product
Table 124. Kyowa Kirin Pharmaceuticals Recent Developments/Updates
Table 125. Hanmi Pharm Corporation Information
Table 126. Hanmi Pharm Description and Business Overview
Table 127. Hanmi Pharm Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Hanmi Pharm Functional Dyspepsia Drug Product
Table 129. Hanmi Pharm Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Functional Dyspepsia Drug Distributors List
Table 133. Functional Dyspepsia Drug Customers List
Table 134. Functional Dyspepsia Drug Market Trends
Table 135. Functional Dyspepsia Drug Market Drivers
Table 136. Functional Dyspepsia Drug Market Challenges
Table 137. Functional Dyspepsia Drug Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Functional Dyspepsia Drug
Figure 2. Global Functional Dyspepsia Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Functional Dyspepsia Drug Market Share by Type in 2023 & 2030
Figure 4. Prokinetic Drugs Product Picture
Figure 5. Gastric Antisecretory Drugs Product Picture
Figure 6. Others Product Picture
Figure 7. Global Functional Dyspepsia Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Functional Dyspepsia Drug Market Share by Application in 2023 & 2030
Figure 9. Hospitals
Figure 10. Drugstores
Figure 11. Global Functional Dyspepsia Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Functional Dyspepsia Drug Market Size (2019-2030) & (US$ Million)
Figure 13. Global Functional Dyspepsia Drug Sales (2019-2030) & (M Units)
Figure 14. Global Functional Dyspepsia Drug Average Price (US$/Unit) & (2019-2030)
Figure 15. Functional Dyspepsia Drug Report Years Considered
Figure 16. Functional Dyspepsia Drug Sales Share by Manufacturers in 2023
Figure 17. Global Functional Dyspepsia Drug Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Functional Dyspepsia Drug Players: Market Share by Revenue in 2023
Figure 19. Functional Dyspepsia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Functional Dyspepsia Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Functional Dyspepsia Drug Sales Market Share by Country (2019-2030)
Figure 22. North America Functional Dyspepsia Drug Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Functional Dyspepsia Drug Sales Market Share by Country (2019-2030)
Figure 26. Europe Functional Dyspepsia Drug Revenue Market Share by Country (2019-2030)
Figure 27. Germany Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Functional Dyspepsia Drug Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Functional Dyspepsia Drug Revenue Market Share by Region (2019-2030)
Figure 34. China Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Functional Dyspepsia Drug Sales Market Share by Country (2019-2030)
Figure 45. Latin America Functional Dyspepsia Drug Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Functional Dyspepsia Drug Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Functional Dyspepsia Drug Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Functional Dyspepsia Drug by Type (2019-2030)
Figure 55. Global Revenue Market Share of Functional Dyspepsia Drug by Type (2019-2030)
Figure 56. Global Functional Dyspepsia Drug Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Functional Dyspepsia Drug by Application (2019-2030)
Figure 58. Global Revenue Market Share of Functional Dyspepsia Drug by Application (2019-2030)
Figure 59. Global Functional Dyspepsia Drug Price (US$/Unit) by Application (2019-2030)
Figure 60. Functional Dyspepsia Drug Value Chain
Figure 61. Functional Dyspepsia Drug Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Functional Dyspepsia Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Functional Dyspepsia Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Functional Dyspepsia Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Functional Dyspepsia Drug Sales (M Units) of Key Manufacturers (2019-2024)
Table 5. Global Functional Dyspepsia Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Functional Dyspepsia Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Functional Dyspepsia Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Functional Dyspepsia Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Functional Dyspepsia Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Functional Dyspepsia Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Functional Dyspepsia Drug, Product Type & Application
Table 12. Global Key Manufacturers of Functional Dyspepsia Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Functional Dyspepsia Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Functional Dyspepsia Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Functional Dyspepsia Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Functional Dyspepsia Drug Sales by Region (2019-2024) & (M Units)
Table 18. Global Functional Dyspepsia Drug Sales Market Share by Region (2019-2024)
Table 19. Global Functional Dyspepsia Drug Sales by Region (2025-2030) & (M Units)
Table 20. Global Functional Dyspepsia Drug Sales Market Share by Region (2025-2030)
Table 21. Global Functional Dyspepsia Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Functional Dyspepsia Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Functional Dyspepsia Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Functional Dyspepsia Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Functional Dyspepsia Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Functional Dyspepsia Drug Sales by Country (2019-2024) & (M Units)
Table 27. North America Functional Dyspepsia Drug Sales by Country (2025-2030) & (M Units)
Table 28. North America Functional Dyspepsia Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Functional Dyspepsia Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Functional Dyspepsia Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Functional Dyspepsia Drug Sales by Country (2019-2024) & (M Units)
Table 32. Europe Functional Dyspepsia Drug Sales by Country (2025-2030) & (M Units)
Table 33. Europe Functional Dyspepsia Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Functional Dyspepsia Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Functional Dyspepsia Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Functional Dyspepsia Drug Sales by Region (2019-2024) & (M Units)
Table 37. Asia Pacific Functional Dyspepsia Drug Sales by Region (2025-2030) & (M Units)
Table 38. Asia Pacific Functional Dyspepsia Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Functional Dyspepsia Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Functional Dyspepsia Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Functional Dyspepsia Drug Sales by Country (2019-2024) & (M Units)
Table 42. Latin America Functional Dyspepsia Drug Sales by Country (2025-2030) & (M Units)
Table 43. Latin America Functional Dyspepsia Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Functional Dyspepsia Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Functional Dyspepsia Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Functional Dyspepsia Drug Sales by Country (2019-2024) & (M Units)
Table 47. Middle East & Africa Functional Dyspepsia Drug Sales by Country (2025-2030) & (M Units)
Table 48. Middle East & Africa Functional Dyspepsia Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Functional Dyspepsia Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Functional Dyspepsia Drug Sales (M Units) by Type (2019-2024)
Table 51. Global Functional Dyspepsia Drug Sales (M Units) by Type (2025-2030)
Table 52. Global Functional Dyspepsia Drug Sales Market Share by Type (2019-2024)
Table 53. Global Functional Dyspepsia Drug Sales Market Share by Type (2025-2030)
Table 54. Global Functional Dyspepsia Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Functional Dyspepsia Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Functional Dyspepsia Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Functional Dyspepsia Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Functional Dyspepsia Drug Price (US$/Unit) by Type (2019-2024)
Table 59. Global Functional Dyspepsia Drug Price (US$/Unit) by Type (2025-2030)
Table 60. Global Functional Dyspepsia Drug Sales (M Units) by Application (2019-2024)
Table 61. Global Functional Dyspepsia Drug Sales (M Units) by Application (2025-2030)
Table 62. Global Functional Dyspepsia Drug Sales Market Share by Application (2019-2024)
Table 63. Global Functional Dyspepsia Drug Sales Market Share by Application (2025-2030)
Table 64. Global Functional Dyspepsia Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Functional Dyspepsia Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Functional Dyspepsia Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Functional Dyspepsia Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Functional Dyspepsia Drug Price (US$/Unit) by Application (2019-2024)
Table 69. Global Functional Dyspepsia Drug Price (US$/Unit) by Application (2025-2030)
Table 70. Bayer Corporation Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Bayer Functional Dyspepsia Drug Product
Table 74. Bayer Recent Developments/Updates
Table 75. Sumitomo Corporation Information
Table 76. Sumitomo Description and Business Overview
Table 77. Sumitomo Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Sumitomo Functional Dyspepsia Drug Product
Table 79. Sumitomo Recent Developments/Updates
Table 80. Cadila Pharmaceuticals Corporation Information
Table 81. Cadila Pharmaceuticals Description and Business Overview
Table 82. Cadila Pharmaceuticals Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Cadila Pharmaceuticals Functional Dyspepsia Drug Product
Table 84. Cadila Pharmaceuticals Recent Developments/Updates
Table 85. Teva Corporation Information
Table 86. Teva Description and Business Overview
Table 87. Teva Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Teva Functional Dyspepsia Drug Product
Table 89. Teva Recent Developments/Updates
Table 90. Johnson & Johnson Corporation Information
Table 91. Johnson & Johnson Description and Business Overview
Table 92. Johnson & Johnson Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Johnson & Johnson Functional Dyspepsia Drug Product
Table 94. Johnson & Johnson Recent Developments/Updates
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Pfizer Functional Dyspepsia Drug Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Sanofi Corporation Information
Table 101. Sanofi Description and Business Overview
Table 102. Sanofi Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Sanofi Functional Dyspepsia Drug Product
Table 104. Sanofi Recent Developments/Updates
Table 105. AstraZeneca Corporation Information
Table 106. AstraZeneca Description and Business Overview
Table 107. AstraZeneca Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. AstraZeneca Functional Dyspepsia Drug Product
Table 109. AstraZeneca Recent Developments/Updates
Table 110. Jiangsu Aosaikang Pharma Corporation Information
Table 111. Jiangsu Aosaikang Pharma Description and Business Overview
Table 112. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Product
Table 114. Jiangsu Aosaikang Pharma Recent Developments/Updates
Table 115. Eisai Corporation Information
Table 116. Eisai Description and Business Overview
Table 117. Eisai Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Eisai Functional Dyspepsia Drug Product
Table 119. Eisai Recent Developments/Updates
Table 120. Kyowa Kirin Pharmaceuticals Corporation Information
Table 121. Kyowa Kirin Pharmaceuticals Description and Business Overview
Table 122. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Product
Table 124. Kyowa Kirin Pharmaceuticals Recent Developments/Updates
Table 125. Hanmi Pharm Corporation Information
Table 126. Hanmi Pharm Description and Business Overview
Table 127. Hanmi Pharm Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Hanmi Pharm Functional Dyspepsia Drug Product
Table 129. Hanmi Pharm Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Functional Dyspepsia Drug Distributors List
Table 133. Functional Dyspepsia Drug Customers List
Table 134. Functional Dyspepsia Drug Market Trends
Table 135. Functional Dyspepsia Drug Market Drivers
Table 136. Functional Dyspepsia Drug Market Challenges
Table 137. Functional Dyspepsia Drug Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Functional Dyspepsia Drug
Figure 2. Global Functional Dyspepsia Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Functional Dyspepsia Drug Market Share by Type in 2023 & 2030
Figure 4. Prokinetic Drugs Product Picture
Figure 5. Gastric Antisecretory Drugs Product Picture
Figure 6. Others Product Picture
Figure 7. Global Functional Dyspepsia Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Functional Dyspepsia Drug Market Share by Application in 2023 & 2030
Figure 9. Hospitals
Figure 10. Drugstores
Figure 11. Global Functional Dyspepsia Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Functional Dyspepsia Drug Market Size (2019-2030) & (US$ Million)
Figure 13. Global Functional Dyspepsia Drug Sales (2019-2030) & (M Units)
Figure 14. Global Functional Dyspepsia Drug Average Price (US$/Unit) & (2019-2030)
Figure 15. Functional Dyspepsia Drug Report Years Considered
Figure 16. Functional Dyspepsia Drug Sales Share by Manufacturers in 2023
Figure 17. Global Functional Dyspepsia Drug Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Functional Dyspepsia Drug Players: Market Share by Revenue in 2023
Figure 19. Functional Dyspepsia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Functional Dyspepsia Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Functional Dyspepsia Drug Sales Market Share by Country (2019-2030)
Figure 22. North America Functional Dyspepsia Drug Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Functional Dyspepsia Drug Sales Market Share by Country (2019-2030)
Figure 26. Europe Functional Dyspepsia Drug Revenue Market Share by Country (2019-2030)
Figure 27. Germany Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Functional Dyspepsia Drug Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Functional Dyspepsia Drug Revenue Market Share by Region (2019-2030)
Figure 34. China Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Functional Dyspepsia Drug Sales Market Share by Country (2019-2030)
Figure 45. Latin America Functional Dyspepsia Drug Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Functional Dyspepsia Drug Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Functional Dyspepsia Drug Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Functional Dyspepsia Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Functional Dyspepsia Drug by Type (2019-2030)
Figure 55. Global Revenue Market Share of Functional Dyspepsia Drug by Type (2019-2030)
Figure 56. Global Functional Dyspepsia Drug Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Functional Dyspepsia Drug by Application (2019-2030)
Figure 58. Global Revenue Market Share of Functional Dyspepsia Drug by Application (2019-2030)
Figure 59. Global Functional Dyspepsia Drug Price (US$/Unit) by Application (2019-2030)
Figure 60. Functional Dyspepsia Drug Value Chain
Figure 61. Functional Dyspepsia Drug Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232